Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
European Journal of Cancer (Oxford, England : 1990)|September 21, 2020
Phase I trials and therapeutic intent in the age of precision oncology: What is a patient's chance of response?Derrick L Tao, Thomas Kartika, Audrey Tran, et al.Blood|May 3, 2021
Aspirin and antiplatelet treatments in cancerDerrick L Tao, Samuel Tassi Yunga, Craig D Williams, et al.European Journal of Haematology|December 14, 2021
Assessing the risk of thromboembolism in cancer patients receiving immunotherapyAbhishek Goel, Arjun Khorana, Thomas Kartika, et al.JCO Precision Oncology|October 26, 2019
Molecular Testing in Patients With Castration-Resistant Prostate Cancer and Its Impact on Clinical Decision MakingDerrick L Tao, Shawna Bailey, Tomasz M Beer, et al.British Journal of Cancer|May 25, 2019
Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumoursCésar Serrano, Adrián Mariño-Enríquez, Derrick L Tao, et al.British Journal of Cancer|February 23, 2019
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumoursCésar Serrano, Adrián Mariño-Enríquez, Derrick L Tao, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2023
Hyper-Dependence on NHEJ Enables Synergy between DNA-PK Inhibitors and Low-Dose Doxorubicin in LeiomyosarcomaAdrian Marino-Enriquez, Jan Philipp Novotny, Doga C Gulhan, et al.Nature|August 20, 2025
Cancer-induced nerve injury promotes resistance to anti-PD-1 therapyErez N Baruch, Frederico O Gleber-Netto, Priyadharsini Nagarajan, et al.Pageof 1